Actinium Pharmaceuticals, Inc. (ATNM) › Total AssetsActinium Pharmaceuticals, Inc. (ATNM) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $1502011: $6.20M2012: $5.79M2013: $5.77M2014: $7.57M2015: $26.59M2016: $22.53M2017: $18.34M2018: $14.89M2019: $11.67M2020: $66.40M2021: $80.39M2022: $114.19M2023: $81.44M2024: $76.90M2025: $51.77M$51.77M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$51.77M-32.7%2024$76.90M-5.6%2023$81.44M-28.7%2022$114.19M+42.1%2021$80.39M+21.1%2020$66.40M+469.0%2019$11.67M-21.6%2018$14.89M-18.8%2017$18.34M-18.6%2016$22.53M-15.3%2015$26.59M+251.3%2014$7.57M+31.3%2013$5.77M-0.4%2012$5.79M-6.6%2011$6.20M+4133564.7%2010$150—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share